123 related articles for article (PubMed ID: 33067747)
1. Medical Immunosuppression and Outcomes in Cutaneous Melanoma: A Population-Based Cohort Study.
Bogach J; Wright FC; Austin J; Cheng SY; Diong C; Sutradhar R; Baxter NN; Look Hong NJ
Ann Surg Oncol; 2021 Jun; 28(6):3302-3311. PubMed ID: 33067747
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Immunosuppressed Patients Who Develop Melanoma: A Population-Based Propensity-Matched Cohort Study.
Austin J; Wright FC; Cheng SY; Sutradhar R; Baxter NN; Look Hong NJ
Ann Surg Oncol; 2020 Aug; 27(8):2927-2948. PubMed ID: 32248374
[TBL] [Abstract][Full Text] [Related]
3. Melanoma incidence, stage, and survival after solid organ transplant: A population-based cohort study in Ontario, Canada.
Park CK; Dahlke EJ; Fung K; Kitchen J; Austin PC; Rochon PA; Chan AW
J Am Acad Dermatol; 2020 Sep; 83(3):754-761. PubMed ID: 32111554
[TBL] [Abstract][Full Text] [Related]
4. β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.
Livingstone E; Hollestein LM; van Herk-Sukel MP; van de Poll-Franse L; Nijsten T; Schadendorf D; de Vries E
Eur J Cancer; 2013 Dec; 49(18):3863-71. PubMed ID: 23942335
[TBL] [Abstract][Full Text] [Related]
5. Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort.
Sanchez A; Rodríguez D; Allard CB; Bechis SK; Sullivan RJ; Boeke CE; Kuppermann D; Cheng JS; Barrisford GW; Preston MA; Feldman AS
Urol Oncol; 2016 Apr; 34(4):166.e7-14. PubMed ID: 26739672
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
Golger A; Young DS; Ghazarian D; Neligan PC
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
[TBL] [Abstract][Full Text] [Related]
7. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
8. Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Tam S; Yao CMKL; Amit M; Gajera M; Luo X; Treistman R; Khanna A; Aashiq M; Nagarajan P; Bell D; El-Naggar A; Migden M; Wong M; Glisson B; Ferrarotto R; Esmaeli B; Rosenthal D; Li G; Weber RS; Myers JN; Gross ND
JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):128-135. PubMed ID: 31804658
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous melanoma in a multiethnic population: is this a different disease?
Hemmings DE; Johnson DS; Tominaga GT; Wong JH
Arch Surg; 2004 Sep; 139(9):968-72; discussion 972-73. PubMed ID: 15381614
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting survival after complete response to isolated limb perfusion in patients with in-transit melanoma.
Zogakis TG; Bartlett DL; Libutti SK; Liewehr DJ; Steinberg SM; Fraker DL; Alexander HR
Ann Surg Oncol; 2001 Dec; 8(10):771-8. PubMed ID: 11776490
[TBL] [Abstract][Full Text] [Related]
11. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes After Pulmonary Metastasectomy for Melanoma: A Population-Based Study.
Hanna TP; Chauvin C; Miao Q; Rizkalla M; Reid K; Peng Y; Nguyen P; Jalink D; Nanji S
Ann Thorac Surg; 2018 Dec; 106(6):1675-1681. PubMed ID: 30171851
[TBL] [Abstract][Full Text] [Related]
13. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
Crocetti E; Mangone L; Lo Scocco G; Carli P
Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
[TBL] [Abstract][Full Text] [Related]
14. Socioeconomic status and survival in older patients with melanoma.
Reyes-Ortiz CA; Goodwin JS; Freeman JL; Kuo YF
J Am Geriatr Soc; 2006 Nov; 54(11):1758-64. PubMed ID: 17087705
[TBL] [Abstract][Full Text] [Related]
15. Melanoma incidence, recurrence, and mortality in an integrated healthcare system: A retrospective cohort study.
Feigelson HS; Powers JD; Kumar M; Carroll NM; Pathy A; Ritzwoller DP
Cancer Med; 2019 Aug; 8(9):4508-4516. PubMed ID: 31215776
[TBL] [Abstract][Full Text] [Related]
16. Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial.
Eggermont AMM; Kicinski M; Blank CU; Mandala M; Long GV; Atkinson V; Dalle S; Haydon A; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJM; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; Krepler C; Ibrahim N; Marreaud S; van Akkooi A; Robert C; Suciu S
JAMA Oncol; 2020 Apr; 6(4):519-527. PubMed ID: 31895407
[TBL] [Abstract][Full Text] [Related]
17. Impact of concomitant immunosuppression on the presentation and prognosis of patients with melanoma.
Frankenthaler A; Sullivan RJ; Wang W; Renzi S; Seery V; Lee MY; Atkins MB
Melanoma Res; 2010 Dec; 20(6):496-500. PubMed ID: 20823779
[TBL] [Abstract][Full Text] [Related]
18. Survival and prognosis of individuals receiving programmed cell death 1 inhibitor with and without immunologic cutaneous adverse events.
Chan L; Hwang SJE; Byth K; Kyaw M; Carlino MS; Chou S; Fernandez-Penas P
J Am Acad Dermatol; 2020 Feb; 82(2):311-316. PubMed ID: 31233857
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.
Fortes C; Mastroeni S; Mannooranparampil TJ; Passarelli F; Zappalà A; Annessi G; Marino C; Caggiati A; Russo N; Michelozzi P
Melanoma Res; 2015 Aug; 25(4):306-11. PubMed ID: 25933208
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]